Molecular Decisions Inc.

Cancer diagnostics: accelerated drug development, enabling accurate cancer treatment selection and rapid efficacy monitoring

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Stanford, CA, US
  • Currency USD
  • Founded March 2013
  • Employees 5
  • Incorporation Type C-corp
  • Website molecular-decisions.com

Company Summary

Molecular Decisions is a spin-off of Stanford University. It is a diagnostics company that creates highly innovative and unique solutions for personalized medical treatment. The company makes nanoscale measurements of proteins and their phosphorylation state and enables
- more efficient drug development, for specific therapeutics actions,
- immediate decisions for the diagnosis and clinical management of cancer
patients,
- save lives.

Team

  • Dean Felsher, M.D., PhD
    Chairman, Director, Founder

    Professor of Medicine-Oncology, Stanford for 18 years

  • Richard Brenner
    Director

    Serial Entrepreneur, Season Executive with over 45 years of senior executive leadership experience, angel investor

  • Alice Fan, M.D.
    Director, Founder

    Assistant Professor of Medicine-Oncology, Stanford University

  • Olga Petrauskene, PhD
    Director

    Molecular Diagnostics Executive, Life Technologies (ThermoFisher), Arbor Vita Corporation

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free